Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP

By Dai Ming-Shen   Chao Tsu-Yi   Kao Woei-Yau   Shyu Rong-Yaun   Liu Tan-Mei  

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 769-774

Springer Publishing Company

Access to resources Recommend Favorite

Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma

By Yang Shih-Hung  

Annals of Hematology, Vol. 87, Iss. 4, 2008-04 ,pp. : 325-327

Springer Publishing Company

Access to resources Recommend Favorite

Therapy-related acute myeloid leukemia in a patient with chronic lymphocytic leukemia treated with rituximab–bendamustine

By García-Muñoz Ricardo   García Diana   Roldán-Galiacho Verónica   Merchante-Andreu Miriam   Campeny-Najara Andrea   Rabasa Pilar  

Annals of Hematology, Vol. 93, Iss. 4, 2014-04 ,pp. : 699-702

Springer Publishing Company

Access to resources Recommend Favorite

Bendamustine for non-Hodgkin lymphoma

By Gribben John  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 123-125

Informa Healthcare

Access to resources Recommend Favorite

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

By Tsutsumi Y.  

Annals of Hematology, Vol. 83, Iss. 1, 2004-01 ,pp. : 58-60

Springer Publishing Company

Access to resources Recommend Favorite